TxCell SA, a developer of cellular immunotherapies based on regulatory T cells (Tregs) for inflammation, autoimmunity and transplantation, today announces it will present its latest manufacturing developments at the 3rd Annual Bioprocessing of Advanced Cellular Therapies Congress to be held in Frankfurt, Germany, on May 29-30, 2018.